Return to homepagePandemic Pact

Targeting ER proteostasis with FDA approved drugs to improve outcome from SARSCoV-2 infection

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Academy of Finland

  • Principal Investigator

    Mikko Airavaara

  • Research Location

    Finland

  • Lead Research Institution

    Helsingin yliopisto

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract